CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 136 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $101,046 | -40.3% | 4,278 | -62.3% | 0.06% | -37.9% |
| Q3 2023 | $169,124 | +23.9% | 11,343 | -9.0% | 0.10% | +27.2% |
| Q2 2023 | $136,547 | -33.7% | 12,470 | -69.0% | 0.08% | +92.9% |
| Q3 2019 | $206,000 | -32.2% | 40,232 | -5.3% | 0.04% | -34.4% |
| Q2 2019 | $304,000 | -26.0% | 42,473 | +37.2% | 0.06% | -92.7% |
| Q1 2019 | $411,000 | +51.7% | 30,947 | -10.1% | 0.87% | +1800.0% |
| Q4 2018 | $271,000 | -32.2% | 34,437 | -4.7% | 0.05% | +12.2% |
| Q3 2018 | $400,000 | -51.9% | 36,120 | -41.7% | 0.04% | -94.4% |
| Q2 2018 | $831,000 | -31.4% | 61,951 | -33.6% | 0.74% | -30.1% |
| Q1 2018 | $1,212,000 | +210.0% | 93,317 | +119.6% | 1.05% | +114.3% |
| Q4 2017 | $391,000 | – | 42,485 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |